Triple-negative breast cancer (TNBC) is a category of breast cancer characterized by the absence of estrogen receptor (ER) expression, progesterone receptor (PR) expression, and human epidermal growth factor receptor 2 (HER2) expression, as determined by immunohistochemistry (IHC) [1]. This evidence concerns the gene PGR and triple-negative breast carcinoma.